ANDA 202975, held by Actavis Labs Fl Inc. Dutasteride; Tamsulosin Hydrochloride.
As of Nov 16, 2026, ANDA 202975 (Dutasteride And Tamsulosin Hydrochloride), held by Actavis Labs Fl Inc, was first approved by FDA on Nov 20, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 20, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dutasteride And Tamsulosin Hydrochloride0.5MG;0.4MG ยท capsule;oral | Dutasteride; Tamsulosin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters